Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOSTRO: Bosutinib in Ph+ CP-CML
NCT02445742Phase 2Completed
- Sponsor
- Fundación PETHEMA
- Start
- May 2015
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bosutinib in chronic myeloid leukemia (CML), sponsored by Fundación PETHEMA. Started May 2015; status: completed.
02
Drugs
bosutinib
03
Conditions
chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT02445742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02445742.